STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and more
The nonprofit Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug, Luvelta
Read full article →Latest Healthcare Policy news from across the web.
The nonprofit Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug, Luvelta
Read full article →Kennedy's "publicly" "available" "calendar," drinking during pregnancy, and more health news from Morning Rounds
Read full article →The DRC has improved testing capacity for Ebola with two facilities operating in or near the epicenter. But this still may not be enough to keep up with a rapidly expanding disease.
Read full article →Hospital execs agree that affordability is a major issue. What to do about it is less clear.
Read full article →“Failing to engage religious and traditional leaders in meaningful ways was a grave misstep in previous Ebola outbreaks,” researchers write.
Read full article →“American science is too valuable to be turned into a political football,” writes David J. Skorton, president of the Association of American Medical Colleges.
Read full article →Many in the diabetes research community expressed shock and disbelief that their colleagues were threatened with arrest for passing out paper copies of an editorial.
Read full article →Trump's Department of Justice is seeking patient files that include the names of young people who have been treated in transgender clinics, as well as hospital staff who have provided care.
Read full article →Spending too much time and money on skin care? Find out what really works to improve skin health and appearance with our one-week newsletter guide. Sign up here.
Read full article →STAT is tracking goals and promises of Robert F. Kennedy Jr. and his Make America Healthy Again movement — successes, incompletes, and fails.
Read full article →Can any of the new obesity medications in development stand out from the pack? Which company just broke records with its IPO? And will the Food and Drug Administration allow…
Read full article →None of STAT's requests for Kennedy's schedule have been completed, and some haven't even been acknowledged.
Read full article →